Variable | SPKT | Â | KTA | Â | ||
---|---|---|---|---|---|---|
pre | post | P-value | pre | post | P-value | |
LV ejection fraction (%) | ||||||
 normal (< 50%) | 33 (79%) | 37 (88%) | 1.00 | 15 (71%) | 13 (63%) | 0.90 |
 slightly reduced (< 40–50%) | 7 (17%) | 4 (9.3%) | 1.00 | 4 (19%) | 5 (24%) | 1.00 |
 moderately reduced (> 30–40%) | 2 (5%) | 1 (2.7%) | 0.39 | 2 (10%) | 2 (9%) | 0.62 |
 reduced (< 30%) | 0 | 0 | 1.00 | 0 | 1 (5%) | 0.89 |
LV hypertrophy (%) | ||||||
 normal (♀49–115 g/m2♂43–95 g/m2) | 12 (28.6%) | 18 (42.9%) | 0.40 | 8 (40%) | 3 (15.8%) | 0.06 |
 slightly (♀116–131 g/m2♂96–108 g/m2) | 18 (42.9%) | 17 (40.5%) | 0.26 | 8 (40%) | 9 (42.1%) | 0.39 |
 moderately (♀132–148 g/m2♂109–121 g/m2) | 9 (21.4%) | 5 (11.9%) | 0.05 | 3 (15%) | 4 (21.1%) | 0.40 |
 high-grade (♀ > 149 g/m2♂ < 122 g/m2) | 3 (7.1%) | 2 (4.8%) | 0.06 | 1 (5%) | 4 (21.1%) | 0.05 |
Hypokinesia (%) | 15 (38%) | 7 (20%) | 0.005 | 5 (23.8%) | 9 (53%) | 0.1 |
Compliance (%) | 23 (58.5%) | 15 (39%) | 0.09 | 8 (44%) | 10 (56%) | 0.328 |